Dr. Erdem Altunel, MD

Dr. Altunel practices at Northern Light Eastern Maine Medical Center in Bangor, Maine, part of Northern Light Health.

Dr. Altunel's NPI, 1619462884, was assigned on June 28, 2018. Dr. Altunel holds Maine license MD27529.

Dr. Altunel's primary practice is Northern Light Eastern Maine Medical Center, at 489 State Street, Bangor, ME 04401 in Penobscot County. The practice phone is (207) 973-7000.

Dr. Altunel's primary practice is Northern Light Eastern Maine Medical Center in Bangor, Maine, part of Northern Light Health. Dr. Altunel is also affiliated with Northern Light Maine Coast Hospital. The medical group on file is Northern Light Eastern Maine Medical Center. Dmand AI also links Dr. Altunel to 3 more hospitals, 2 hospices, 1 breast imaging center and 1 group practice or clinic, each named with a free account. Dr. Altunel's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Altunel practices, 9 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Altunel's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Altunel's licenses on file in 2 states: Maine and Massachusetts.

CMS data shows 60 Medicare services from Dr. Altunel across 2 procedure codes in 2024, all of them office visits, for 83 Medicare patients. Medicare paid $4,997 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 83 Medicare patients who saw Dr. Altunel in 2024. The largest group is 65 to 74, with 31 patients. 73% of them have high blood pressure, and 70% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Altunel's median patient age at 69, with 60% women.

In 2024, Dr. Altunel wrote 238 Medicare Part D claims for 64 patients. 78% of them were for generic drugs. CMS names the drug for 79 of them, across 5 drugs with 11 or more claims each, at $13,254 in total drug cost. In 2023, CMS named 129 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Altunel for performance year 2024, reported as part of a group. Dr. Altunel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Altunel as offering telehealth.

Dmand AI links 6 papers to Dr. Altunel, published from 2019 to 2020. 2020 was the busiest year, with 4. The most frequent topics are Antineoplastic Agents, Cell Line, Tumor and Colorectal Neoplasms. Dr. Altunel's most frequent co-authors are William C. Eward, DVM, MD, Olga N. Kozyreva, MD and Christopher R. Mantyh, MD.

CMS Open Payments shows 5 general payments to Dr. Altunel from 4 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 68% of the total. Abbvie Inc. paid the most, $207.